Psychological factors negatively affect quality-of-life scores in chronic obstructive pulmonary disease (COPD) patients, according to a recent study published in the International Journal of Chronic Obstructive Pulmonary Disease.
Psychological factors negatively affect quality-of-life scores in chronic obstructive pulmonary disease (COPD) patients, according to a recent study published in the International Journal of Chronic Obstructive Pulmonary Disease.
While quality of life varies greatly among patients with COPD, it is often unrelated to physiological impairment. The study examined factors that are associated with poor quality of life, focusing on psychological measures that can easily be controlled with intervention and treatment.
The researchers analyzed Birmingham (UK) COPD cohort data to determine factors affecting quality of life. The population was divided into 3 patient groups, including patients with diagnosed COPD on general practitioner registers, newly identified COPD patients from a linked case-finding study, and participants from the case-finding study with chronic respiratory symptoms without airflow obstruction.
Patients received questionnaires every 6 months over a 3-year period assessing the Medical Research Council breathlessness scale, lung function, muscle strength, and exercise capacity. Another questionnaire was administered during that time which focused on depression, anxiety, dysfunctional breathing, illness perceptions, and agoraphobia avoidance.
The results showed a wide variation of perceived quality of life impairment due to COPD in the population. Depression, anxiety, and negative health beliefs have significant impacts on patients’ experience with COPD. Illness perception has been found to be a determinant of behavior that has improved treatment adherence and functional recovery in patients. While psychological issues are common in patients with COPD, there is little evidence in supporting the use of intervention. Small studies have shown that relaxation, cognitive behavioral therapy, self-management and antidepressant medication can improve quality of life.
The authors concluded that there are many factors affecting quality of life in COPD patients. Many treatments to improve quality of life are nonpharmacologic approaches, including pulmonary rehabilitation being an effective way to manage the disease. Further research on psychological intervention needs to be pursued.
“The clinical focus in COPD is generally directed toward biologic factors such as physiologic impairment and airways inflammation, with a predominant focus on pharmacologic interventions,” the authors concluded. “However, along with smoking cessation, nonpharmacologic approaches are also very important in improving patient outcomes, with pulmonary rehabilitation now recognized as being a key element in overall disease management.”
References
Brien SB, Stuart B, Dickens AP. Independent determinants of disease-related quality of life in COPD—scope for nonpharmacologic interventions? Int J Chron Obstruct Pulmon Dis. 2018;13(1):247-256.
A Pulmonologist on Why You Should Think About Respiratory Health and the Lungs
November 16th 2021On this episode of Managed Care Cast, we speak with MeiLan K. Han, MD, MS, the author of a book released this month called Breathing Lessons: A Doctor’s Guide to Lung Health. Han, a pulmonologist, gives an inside tour of the lungs and how they work, zooms out to examine the drivers of poor respiratory health, and addresses policy changes that are needed to improve lung health.
Listen
NIVO Score Accurately Predicts Mortality, Noninvasive Ventilation Failure in Patients With AECOPD
October 28th 2024The Noninvasive Ventilation Outcomes (NIVO) score is a reliable predictor of intensive care unit (ICU) mortality, 1-year mortality, and NIV failure in patients with acute exacerbations of COPD (AECOPD), offering valuable guidance for personalized patient management.
Read More
Preventing Respiratory Illness and Death Through Tighter Air Quality Standards
June 1st 2021On this episode of Managed Care Cast, a research scholar at the Marron Institute of Urban Management at New York University discusses the latest findings in the Health of the Air report, which was presented at the recent American Thoracic Society 2021 International Conference.
Listen
Ineligibility, Limitations to PR Uptake in Patients With AECOPD
October 15th 2024Two posters at the CHEST 2024 annual meeting revealed that 18% of eligible patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) participated in post-discharge pulmonary rehabilitation (PR), with ineligibility significantly limiting uptake.
Read More
Opioids, Benzodiazepines Linked to Higher Mortality in Older Patients With COPD
September 30th 2024A study found that opioid use, with or without benzodiazepines, significantly increases long-term mortality risk in patients with chronic obstructive pulmonary disease (COPD) over the age of 60 years.
Read More